Navigation Links
PartnerRe Declares Dividends on Series C Cumulative Redeemable Preferred Shares and Series D Cumulative Redeemable Preferred Shares and Corrects Ex-Dividend Trading Date for Common Shares
Date:2/7/2008

PEMBROKE, Bermuda, Feb. 7 /PRNewswire-FirstCall/ -- PartnerRe Ltd. (NYSE: PRE) announced that its Board of Directors has declared a dividend for the period December 1, 2007 - February 29, 2008 of $0.421875 per share on the Company's 6.75% Series C Cumulative Redeemable Preferred Shares, and $0.40625 per share on the Company's 6.5% Series D Cumulative Redeemable Preferred Shares. The dividends will be payable on March 3, 2008, to shareholders of record on February 22, 2008.

PartnerRe Ltd. is a leading global reinsurer, providing multi-line reinsurance to insurance companies. The Company, through its wholly owned subsidiaries, also offers alternative risk products that include weather and credit protection to financial, industrial and service companies. Risks reinsured include property, casualty, motor, agriculture, aviation/space, catastrophe, credit/surety, engineering, energy, marine, specialty property, specialty casualty, multiline and other lines, life/annuity and health, and alternative risk products. For the year ended December 31, 2007, total revenues were $4.2 billion, total assets were $16.0 billion, and at December 31, 2007 total capital was $5.2 billion and total shareholders' equity was $4.3 billion.

PartnerRe on the Internet: http://www.partnerre.com

Contacts: PartnerRe Ltd. Sard Verbinnen & Co.

(441) 292-0888 (212) 687-8080

Investor Contact: Robin Sidders Drew Brown/Jane Simmons

Media Contact: Celia Powell


'/>"/>
SOURCE PartnerRe Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Young Innovations, Inc. Announces Results for 4th Quarter and the Year and Declares Dividend
2. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
3. Cardinal Health Announces Resignation of Director; Declares Regular Quarterly Dividend
4. Mylan Declares Quarterly Preferred Stock Dividend
5. NHP Increases Its Quarterly Common Dividend by $0.03 and Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
6. BD Board Declares Dividend
7. Assurant Board of Directors Declares Quarterly Dividend of $0.12 per Share
8. Wyeth Declares Common and Preferred Stock Dividends
9. STERIS Corporation Declares Regular Quarterly Dividend
10. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
11. Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... ... ... from Greet, S.C., wants to offer people a new way to care for their feet. ... so I know the importance of proper foot care," he said. "In order to enable ... The FOOT-TRAN SYSTEM enables a user to clean and exfoliate the bottoms of his or ...
(Date:3/30/2017)... Washington, DC (PRWEB) , ... March 30, 2017 ... ... scientists and organizations submitted a letter to President Trump expressing their support for ... two medical doctors, two Ph.D. scientists and one medical journalist, will hold a ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, ... each year develop other types of metastatic brain tumors(3). Though most meningiomas are benign, ... efforts focus on finding more effective treatment options, the San Diego Gamma Knife ...
(Date:3/29/2017)... ... 30, 2017 , ... Grass pollen is the main cause of hay fever in the United ... for grass pollen runs from May to July each year; with the worst time for ... HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they ...
(Date:3/29/2017)... ... March 30, 2017 , ... Sublime Naturals and its founder, Kathy Heshelow, are ... it has been used for thousands of years. , "The West has caught on, ... " Turmeric: How to Use it For Your Wellness. Overcome Inflammation, Enemy of the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... , Mar. 29, 2017 Research and Markets ... Market 2017-2021" report to their offering. ... The global energy-based aesthetic devices market ... The report, Global Energy-Based Aesthetic Devices Market 2017-2021, ... from industry experts. The report covers the market landscape and its ...
(Date:3/29/2017)... Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving ... Carmine N. Stengone , president and chief executive officer, will present ... th Annual Healthcare Conference on Wednesday, April 5, 2017, at ... Hotel in New York City . ... ...
(Date:3/29/2017)... 29, 2017 Research and Markets has announced the ... Therapy Centers & Forecast" report to their offering. ... Proton Therapy Market in Italy ... value in 2016. There are currently three proton therapy centers in ... more patients. In Italy , the first patients were ...
Breaking Medicine Technology: